Coredio, a digital health company developing the first software-as-a-medical-device (SaMD) platform dedicated to heart failure (HF) hemodynamic assessment, today announced that the U.S. Food and Drug ...
BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is characterized by impaired contractility and high ...
Heart tissue analysis before and after lvad support highlights key stress-related metabolic pathways
Researchers have identified a key protein that may help failing hearts regain function, offering new insight into why some ...
Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...
Medical Device Network on MSN
Coredio’s AI heart failure software secures breakthrough designation
Coredio’s AI software is used to monitor HF parameters via wearables and standard blood pressure cuffs.
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
A myocardial infarction (MI), or heart attack, doesn't just damage the cardiovascular system—it can dramatically reshape how ...
In this episode, Jeffrey Farber, MD, President & CEO of The New Jewish Home, discusses the organization’s accredited heart failure program within a skilled nursing facility setting. He shares how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results